Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Before investing in cryptocurrency, it's crucial to understand the market. Learn key insights to prepare yourself for potential investments.
24,812 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
A Nike brand moat argument resurfaces as investors weigh the stock's downside and potential upside. A Nike analyst po...
As mortgage costs stay elevated, Opendoor racked up another quarterly loss. Forget opendoor technologies: this turns ...
Reality TV alum and Candy Kittens founder Jamie Laing says content creators will power the next wave of Fortune 500 b...
After June 5 volatility unsettles tech stocks, investors are turning to a dividend-focused chip index for steady inco...
Analysts rolled out a fresh slate of calls on Block, Cognizant, First Solar and others as markets navigate midweek vo...
Medicare's first round of drug-price negotiations slashes list prices on 10 widely used drugs by up to 79% starting J...
The SNPD ETF is widening its search for dividend growth by applying a 10-year growth screen to identify the next gene...
As the U.S. nears its 250th birthday, Wendy Schmidt unveils a major science funding program aimed at accelerating bre...
Rocket Lab unveiled an approximately $8 billion plan to acquire Iridium, aiming to become a full-stack space operator...
As AI infrastructure spending persists into July, Teradyne, Ouster, and Vishay Precision Group lead a rally in infras...
Mega-cap tech now drives most S&P 500 gains, leaving the rest of the market with thinner support. Here’s what investo...